State of Wyoming Sells 3,873 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

State of Wyoming lowered its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 51.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,715 shares of the company's stock after selling 3,873 shares during the period. State of Wyoming's holdings in Henry Schein were worth $257,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in HSIC. Barclays PLC increased its position in Henry Schein by 6.9% during the third quarter. Barclays PLC now owns 286,475 shares of the company's stock worth $20,882,000 after buying an additional 18,458 shares during the last quarter. Fifth Third Bancorp boosted its holdings in Henry Schein by 11.0% during the fourth quarter. Fifth Third Bancorp now owns 3,366 shares of the company's stock valued at $233,000 after acquiring an additional 333 shares during the period. Olstein Capital Management L.P. increased its stake in shares of Henry Schein by 17.2% in the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock worth $7,543,000 after purchasing an additional 16,000 shares during the period. Robeco Institutional Asset Management B.V. acquired a new position in shares of Henry Schein during the 4th quarter worth about $763,000. Finally, Cibc World Market Inc. boosted its stake in Henry Schein by 2.8% during the 4th quarter. Cibc World Market Inc. now owns 360,018 shares of the company's stock valued at $24,913,000 after purchasing an additional 9,954 shares during the period. 96.62% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

HSIC has been the subject of a number of recent research reports. Wall Street Zen lowered Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. UBS Group cut their target price on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research report on Wednesday, February 26th. Piper Sandler cut their price objective on Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a report on Wednesday, April 30th. Barrington Research dropped their target price on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a research report on Tuesday, May 6th. Finally, Wells Fargo & Company reduced their price target on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $79.30.

Henry Schein Price Performance

HSIC traded up $2.01 on Tuesday, hitting $73.66. 1,915,580 shares of the stock were exchanged, compared to its average volume of 1,663,158. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49. The firm has a market capitalization of $8.97 billion, a price-to-earnings ratio of 30.31, a PEG ratio of 2.13 and a beta of 0.87. The business has a 50-day moving average of $67.47 and a two-hundred day moving average of $71.56.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping analysts' consensus estimates of $1.11 by $0.04. The company had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein's revenue was down .1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.10 EPS. Sell-side analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Insider Transactions at Henry Schein

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the firm's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares in the company, valued at approximately $1,762,147.20. This trade represents a 9.50% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Bradford C. Connett sold 4,036 shares of the company's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares in the company, valued at approximately $4,460,251.20. This represents a 6.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.08% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.